NCT02017444View on ClinicalTrials.gov

Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 25, 2014

Primary Completion Date

December 19, 2016

Study Completion Date

December 19, 2016

Conditions
Idiopathic Intracranial Hypertension
Interventions
DRUG

AZD4017

OTHER

Placebo

Matched placebo (matched to AZD4017 arm)

Trial Locations (1)

B15 2TH

University Hospital Birmingham (Queen Elizabeth Hospital), Birmingham

All Listed Sponsors
lead

University of Birmingham

OTHER

NCT02017444 - Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. | Biotech Hunter | Biotech Hunter